Market Cap 4.06M
Revenue (ttm) 5.05M
Net Income (ttm) -7.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -139.41%
Debt to Equity Ratio 0.00
Volume 4,500
Avg Vol 5,344
Day's Range N/A - N/A
Shares Out 1.37M
Stochastic %K 39%
Beta 0.86
Analysts Strong Sell
Price Target $12.00

Latest News on RKDA

Arcadia Biosciences (RKDA) Announces Leadership Transition

Jul 9, 2024, 8:02 AM EDT - 9 months ago

Arcadia Biosciences (RKDA) Announces Leadership Transition


Arcadia Biosciences (RKDA) Announces Strategic Review

Jul 20, 2023, 8:02 AM EDT - 1 year ago

Arcadia Biosciences (RKDA) Announces Strategic Review


4 Cheapest Defensive Stocks You Should Think About

Feb 1, 2023, 7:18 AM EST - 2 years ago

4 Cheapest Defensive Stocks You Should Think About

LOCL


Arcadia Biosciences (RKDA) Announces CFO Transition

Nov 30, 2022, 4:30 PM EST - 2 years ago

Arcadia Biosciences (RKDA) Announces CFO Transition


Arcadia Biosciences Inc (RKDA) Q3 2022 Earnings Call Transcript

Nov 10, 2022, 6:54 PM EST - 2 years ago

Arcadia Biosciences Inc (RKDA) Q3 2022 Earnings Call Transcript